# Association of Hydroxychloroquine, BRAF and MEK Inhibitors in Metastatic Melanoma : a Retrospective Case-control Study.

> **NCT04760080** · — · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 31 (actual)

## Conditions studied

- Dermatology and Oncology

## Interventions

- **OTHER:** pre-treatment data
- **OTHER:** during study treatment

## Key facts

- **NCT ID:** NCT04760080
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-01
- **Primary completion:** 2020-10-01
- **Final completion:** 2020-10-01
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2021-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04760080

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04760080, "Association of Hydroxychloroquine, BRAF and MEK Inhibitors in Metastatic Melanoma : a Retrospective Case-control Study.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04760080. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*